
Aardvark Therapeutics, Inc. (AARD) - Yahoo Finance
Find the latest Aardvark Therapeutics, Inc. (AARD) stock quote, history, news and other vital information to help you with your stock trading and investing.
Aardvark Therapeutics (AARD) Stock Price & Overview
5 days ago · A detailed overview of Aardvark Therapeutics, Inc. (AARD) stock, including real-time price, chart, key statistics, news, and more.
Home - Aardvark Therapeutics
Aardvark Therapeutics is a clinical-stage biopharmaceutical company developing novel, small-molecule therapies designed to inhibit hunger and treat metabolic diseases. Hunger and appetite are distinct …
AARD Stock Price | Aardvark Therapeutics Inc. Stock Quote
6 days ago · AARD | Complete Aardvark Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
AARD: Aardvark Therapeutics Inc - Stock Price, Quote and News - CNBC
5 days ago · Get Aardvark Therapeutics Inc (AARD:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
AARD Stock Price Quote | Morningstar
6 days ago · See the latest Aardvark Therapeutics Inc stock price (AARD:XNAS), related news, valuation, dividends and more to help you make your investing decisions.
Aardvark Therapeutics Inc (AARD) Stock Price & News - Google
Get the latest Aardvark Therapeutics Inc (AARD) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Aardvark Therapeutics (AARD) Stock Price, News & Analysis
6 days ago · Should You Buy or Sell Aardvark Therapeutics Stock? Get The Latest AARD Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat.
Aardvark Therapeutics Stock Quote: AARD Stock News, Quotes, …
Mar 27, 2025 · AARD, Aardvark Therapeutics - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines
Why Aardvark Therapeutics (AARD) paused late-stage ARD-101 trials …
Aardvark Therapeutics, Inc. (NASDAQ:AARD) is one of the penny stocks with potential to rise 1000 percent. Aardvark Therapeutics said on March 23, 2026, that it had voluntarily paused its Phase 3 ...